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INTRODUCTION
The patients with liver cirrhosis (LC) frequently
show postprandial hyperglycemia. From 10 to 40%
of them fall into diabetes mellitus (DM) and about
40% of them become impaired glucose intolerance
(IGT), whereas 30% of them have kept normal glu-
cose tolerance (NGT) (1, 2). It is supposed that
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insulin resistance may contribute to postprandial
hyperglycemia since plasma immunoreactive insulin
(IRI) and C peptide immunoreactivity (CPR) levels
are increased in patients with LC (3). Irrespective
of etiology, insulin resistance is observed in the pa-
tients with LC even before occurring glucose intol-
erance (4). Furthermore, diabetes (5, 6) or obesity
(5, 7) characterized by insulin resistance increases
cancer risk in cirrhosis.
It has been reported that hepatic glucose pro-
duction in the patients with LC is normal and de-
creased (8), however, insulin-induced glucose up-
take in the peripheral tissue is markedly decreased
(9). In contrast, hepatic insulin resistance is seen in
cirrhotic patients with DM but not in patients with
LC alone (9-11). Thus, the role of insulin resistance
on hepatic glucose uptake in the patients with LC
has remained unclear.
There was no clear evidence that etiology, dura-
tion and degree in the patients with LC would be
related to glucose intolerance (12). Furthermore,
disorder in glucose metabolism is not always seen
in a comparative number of cirrhotic patients and
the patients with advanced LC is not always devel-
oped IGT and DM (12).
In this study, the relation between glucose uptake
of peripheral and liver tissue evaluated by the hyper-
insulinemic euglycemic clamp combined with 0.2
g/kg oral glucose load (HECGL), and the biochemi-
cal and metabolic parameters of liver function was
examined in the patients with LC divided into groups
by World Health Organization criteria in 75 g oral
glucose tolerance test (OGTT) (13). HECGL (14-
16) which enabled us to measure the peripheral and
hepatic glucose uptake simultaneously and precisely
was conducted in 61 patients with LC.
SUBJECTS AND METHODS
Subjects
Sixty-one patients with LC (16 hepatitis B virus
(HBV)-infected LC, 35 hepatitis C virus (HCV)-
infected LC, 3 HBV- and HCV-infected LC, 2 alco-
holic LC and 5 LC with unknown etiology) and 34
age matched control without liver disease (Control)
were enrolled for this study. None of the patients
received any medication affecting glucose tolerance,
including oral hypoglycemic agents or insulin injec-
tions. All patients with LC were diagnosed by liver
biopsy, laboratory tests and ultrasound sonography ;
alcoholic liver disease was diagnosed in habitual
drinkers who consumed more than 30 g of ethanol
daily. None of the patients had ascites, jaundice or
hepatic encephalopathy. 48 and 13 patients in 61 LC
patients were classified as Child-Pugh A and B, re-
spectively. The clinical and laboratory data are sum-
marized in Table 1. The levels of white blood cell,
platelet, albumin, cholinesterase, total cholesterol
and triglyceride in the patients with LC were signifi-
cantly lower than those in Control ; body mass index
and the levels of serum aspartate aminotransferase,
Table 1. Clinical and laboratory data of age matched control and patients with liver cirrhosis
Control Patients
(n=34)
LC-total
(n=61)
LC-NGT
(n=21)
LC-IGT
(n=12)
LC-DM
(n=28)
Age (y) 61.72.1 64.41.3 65.92.6 61.92.5 64.41.9
Body mass index (kg/m2) 21.80.6 23.30.4 1 22.60.7 23.61.0 23.50.7
White blood cell (/μL) 6872442 5275319 1 4645336 1 5700548 5557586
Red blood cell (106/μL) 4.180.10 4.030.07 4.000.11 4.300.11 3.950.12
Platelet (104/μL) 22.51.2 15.11.5 1 13.62.2 1 17.42.4 15.22.7
Prothrombin time (sec) 12.30.5 13.90.2 1 13.80.3 1 13.70.2 1 14.00.4 1
Aspartate aminotransferase (IU/L) 345 655 1 678 1 6713 638 1
Alanine aminotransferase (IU/L) 366 564 1 536 548 585 1
Total bilirubin (mg/dl) 0.90.3 1.00.1 0.80.1 1.30.2 1.10.1
Albumin (g/dl) 3.90.1 3.70.1 1 3.70.1 3.60.2 3.60.1
Cholinesterase (IU/L) 26220 18811 1 16915 1 19226 20118
Total cholesterol (mg/dl) 1739.5 1494.9 1 1466.9 16813.1 1447.3 1
Triglyceride (mg/dl) 13722.2 884.6 1 845.2 1 8811.3 908.0 1
Ammonia (μg/dl) 34.82.4 45.03.5 1 47.25.7 37.13.2 46.96.2
Indocyanine green retention rates
at 15 minutes (%) 9.2
1.5 25.41.9 1 25.32.6 1 26.24.4 1 25.13.2 1
All values are meanSE. 1p0.05 vs. Control
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alanine aminotransferase and ammonia, prothrombin
time, and indocyanine green retention rates at 15
minutes were significantly higher than those in Con-
trol .
The purpose of the study was fully explained to
all subjects, and their informed and written consent
were obtained. The study confirmed to the 1975
Helsinki Declaration on ethical guidelines for clini-
cal investigations.
Oral glucose tolerance test
After overnight fasting for 12 h, the patients in-
gested 75 g of dextrose (Torelan G 75, Shimizu Co.,
Japan) within 5 min. Venous blood was drawn for
measuring plasma glucose (PG), IRI and CPR lev-
els before, and at 15, 30, 60 and 120 min after the
oral glucose load (OGL). The definition of DM, im-
paired fasting glucose (IFG), IGT and NGT were
based on World Health Organization criteria (13).
In brief, patients were classified as LC-DM when
fasting plasma glucose (FPG) level was126 mg/
dl or when PG level at 2-hour OGTT was200 mg/
dl. LC-IGT was defined as FPG level of126 mg/
dl and 2-hour OGTT PG level of 140 to 199 mg/dl.
Thus, patients with LC-IFG had FPG level of 110 to
125 mg/dl and 2-hour OGTT PG level of140 mg/
dl. Patients with LC-NGT had FPG level of110
mg/dl and 2-hour OGTT PG level of140 mg/dl.
Hyperinsulinemic euglycemic clamp combined with
oral glucose load
Subjects were admitted to the laboratory at
8 : 00AM after an overnight fast. They voided, were
weighed, and then remained supine for the duration
of the procedure. The details of HECGL have been
described previously (14-16). In short, a polyethyl-
ene catheter was inserted into an antecubital vein
in a retrograde manner to administer glucose (20%
of glucose) and insulin infusion. A second catheter
was inserted into a dorsal hand vein on the contra-
lateral arm in the retrograde fashion and kept in
a warming device to arterialize the venous blood.
Blood samples were drawn at baseline to determine
Fasting PG levels, serum IRI levels and CPR levels.
Insulin-mediated whole body glucose uptake was
measured using an artificial pancreas (Model STG-
22 Nikkiso, Tokyo, Japan), according to DeFronzo’s
method (17). An infusion of 20% of glucose solution
was started at baseline, and the rate was adjusted
to clamp the glucose level at 100 mg/dl during the
clamp study. PG levels were checked at 30-second
intervals throughout the investigation. Data on total
body glucose uptake represented the mean values
for the glucose infusion rate (GIR) during the final
30 minutes of infusion. After determining the base-
line GIR during the hyperinsulinemic euglycemic
clamp described above, glucose was orally admin-
istered at a dose of 0.2 g/kg body weight. Thereaf-
ter, the hyperinsulinemic euglycemic clamp was
continued and the extent of decrease in GIR was
monitored for 90 min in order to evaluate hepatic
glucose uptake (HGU), which was used as a pa-
rameter of insulin sensitivity in the liver.
Calculation of hepatic glucose uptake
After an OGL during hyperinsulin emiceuglyce-
mic clamp, the glucose appearance rate (Ra(t)) is
calculated by the formula,
Ra(t)=[OGL(t)-HGU(t)]+GIR(t) [1]
where OGL(t), the rate of absorption of OGL by the
intestine at time t ; HGU(t), the rate of HGU of OGL
at time t ; and GIR(t), GIR at time t. Glucose disap-
pearance rate from the systemic circulation (RdT(t))
is calculated by the formula,
RdT(t)=RdP(t)+RdS(t) [2]
where RdP(t) and RdS(t) are extra-splanchnic and
splanchnic glucose disappearance rates from sys-
temic circulation at time t, respectively. Under hyper-
insulinemic euglycemic clamp conditions, Ra(t) is
equal to RdT(t), therefore
RdP(t)+RdS(t)=[OGL(t)-HGU(t)]+GIR(t) [3]
HGU can be calculated from the difference between
the amount of ingested glucose and the summation
of GIR decrements after glucose ingestion.
Σ(HGU(t)+RdS(t))=ΣOGL(t)-Σ(RdP(t)-GIR(t))
[4]
Total hepatic glucose uptake was expressed as a per-
centage of OGL.
Assessment of energy metabolism
To maintain the resting energy expenditure
(REE) and substrate oxidation, in preprandial and
postprandial thermogenesis after an overnight fast,
the patients and Control were asked to maintain a
supine position throughout the study period, and to
avoid activity during the indirect calorimetry (Chest
MI, Tokyo, Japan). The measurements of O2 con-
sumption and CO2 production were computed and
printouts obtained at 1 min intervals ; the measure-
ments were continued until steady-state equilibrium
was achieved. The average O2 consumption and CO2
production were used in calculating the energy ex-
penditure ; the mean values during the last 10 min of
the measurement interval were used for calculation.
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The machine was calibrated before each study and
at intervals throughout the experiment. The basal
energy expenditure was estimated according to the
equation reported by Harris and Benedict (18), and
the ratio of REE to basal energy expenditure is ex-
pressed as the %REE. The %REE was used as the ac-
tual index of energy expenditure to compare the val-
ues of energy expenditure among different individu-
als. The non-protein respiratory quotient (npRQ)
was calculated from measurements of daily urinary
nitrogen excretion. Measurements were taken at
8 : 30AM, 11 : 30AM and 2 : 30PM. The patients
were asked to stay in bed for at least 30 minutes
before each measurement, but some mobility was
allowed between each set of measurements. Break-
fast and lunch were given at 9 : 00AM and 12 : 00
noon, respectively, and consumed within 30 min. Pa-
tients received standard hospital food, and their die-
tary intake was recorded and the amounts of energy,
protein, fat, and carbohydrate were calculated using
Japanese standard tables of food composition (19).
The energy and nutritional intake was not signifi-
cantly different among the groups. Blood samples
were taken to determine the PG and non-esterified
fatty acids (NEFA) just before the indirect calorime-
try measurements.
Measurement and statistical analysis
Glucose was measured by the glucose oxidase
method (Hitachi 736 Auto Analyser, Hitachi Co.,
Tokyo, Japan). IRI and CPR were analyzed by radio-
immunoassay (Eiken, Tokyo, Japan). Serum NEFA
concentrations were assayed using an acyl-CoA
oxidase-based colorimetric kit (Wako NEFA-C,
Wako Chemicals, Osaka, Japan). All data were pre-
sented as meanSE, unless otherwise specified.
Statistical comparisons were assessed, where appro-
priate, using one-way ANOVA and unpaired t-test
analysis. P values0.05 were considered statistically
significant.
RESULTS
1) Classification of the patients with LC by 75 g
OGTT
By 75 g OGTT, the 61 patients with LC were di-
vided into 21 (34.4%) in LC-NGT, 12 (19.7%) in LC-
IGT, 28 (45.9%) in LC-DM, but there were no pa-
tients in LC-IFG (Figure 1). FPG level was normal
in 50 (82.0%) patients with LC. PG in LC-total pa-
tients was higher than that in Control at 15, 30, 60
and 120 min. There was not significant difference
between Control and LC-DM patients, but PG in
LC-DM patients was higher than that in LC-NGT
patients and LC-IGT patients at fasting state. Post-
prandial PG in LC-DM patients was higher than that
in LC-NGT patients at 30, 60, 120 min and that in
LC-IGT patients at 120 min, respectively. IRI in LC-
total patients was higher than that in Control at 60
Figure 1. Plasma glucose (A), insulin (B), and C-peptide (C), levels during 75 g oral glucose tolerance test in control ( ) and pa-
tients with liver cirrhosis (LC) total ( ), NGT : normal glucose tolerance ( ), IGT : impaired glucose tolerance ( ), DM : diabetes
mellitus ( ). All values are meanSE. *p0.05 vs. Control, p0.05 vs. LC-NGT, p0.05 vs. LC-IGT.
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and 120 min. There was not significant difference
between Control and LC-total patients at fasting
state. The Insulin level at fasting state tended to be
higher with insulin resistance, but it was not signifi-
cant. IRI in LC-DM patients was lower than that in
LC-NGT patients at 30 min. Similarly, CPR in LC-
DM patients was lower than that in LC-NGT pa-
tients at 30 min. CPR in LC-total patients was higher
than that in Control at 0 and 120 min. The values
of area under the curve (AUC) of PG, IRI and CPR
levels in LC-total patients were significantly higher
than those in Control. The AUC of PG in LC-DM
patients higher than that in Control, LC-NGT pa-
tients and LC-IGT patients. That in LC-IGT patients
higher than that in Control and LC-NGT patients.
The AUC of CPR in LC-IGT patients higher than
that in Control (Figure 2).
The ratios of AUC of IRI to AUC of CPR (AUC
IRI/AUC CPR), a rough measurement for porto-sys-
temic shunting of insulin, in LC-total patients, LC-
NGT patients, LC-IGT patients and LC-DM patients
tended to be higher than those in Control, but not
significant.
2) Evaluation of insulin sensitivity
Comparable and stable PG levels, clamped at 1.00
g/L, were achieved over the last 30 min in patients
with LC and Control with HECGL. Both GIR and
HGU in LC-total patients were significantly lower
than those in Control (Figure 3). GIR in LC-NGT,
Figure 2. Area under the curve of plasma glucose (PG), immunoreactive insulin (IRI) and C-peptide immunoreactivity (CPR) for
120 min after 75 g oral glucose tolerance test in control and patients with liver cirrhosis. All values are meanSE. AUC : area under
the curve, LC : liver cirrhosis, NGT : normal glucose tolerance, IGT : impaired glucose tolerance, DM : diabetes mellitus. *p0.05 vs.
Control, p0.05 vs. LC-NGT, p0.05 vs. LC-IGT.
Figure 3. Glucose infusion rate and hepatic glucose uptake by hyperinsulinemic euglycemic clamp combined with oral glucose load
in control and patients with liver cirrhosis. All values are meanSE. LC : liver cirrhosis, NGT : normal glucose tolerance, IGT : impaired
glucose tolerance, DM : diabetes mellitus. *p0.05 vs. Control, p0.05 vs. LC-NGT.
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LC-IGT and LC-DM patients showed significantly
lower than that in Control. Furthermore, GIR in LC-
DM patients showed significantly lower than that in
LC-NGT patients. Thus, GIR levels proportionally
became lower with the severity of glucose intoler-
ance. HGU in LC-DM patients showed significantly
lower than that in Control.
3) Comparison of biochemical and metabolic fea-
tures in LC patients
Age was not significant differences among each
group. Blood chemistry data exhibited significant
differences between Control and LC patients (Table
1). In energy metabolism, the %REE values in the
patients with LC and those groups were similar to
those of Control under fasting and postprandial con-
ditions (Table 2). Fasting npRQ in LC-total patients
was significantly lower than that in Control, and the
value tended to decrease according to the severity
of glucose intolerance in the patients with LC. Fur-
thermore, Fasting npRQ in LC-DM patients showed
significantly lower than that in Control. Such find-
ings were not observed after food ingestion. There-
fore, the increased npRQ levels after meal, desig-
nated as npRQ, in the patients with LC were higher
than those in Control, and the value tended to in-
crease according to the severity of glucose intoler-
ance in the patients with LC. Furthermore,npRQ
in LC-DM patients showed significantly higher than
that in Control. Fasting and postprandial glucose
concentrations in LC-total patients were significantly
higher than those in Control. PG in LC patients, at
11 : 30AM and 2 : 30PM, were elevated with the se-
verity of glucose intolerance, which was similar to
those of 75 g OGTT. The serum fasting NEFA con-
centrations in LC-total patients were significantly
higher than those in Control and tended to increase
with the severity of impaired glucose metabolism
in patients with LC. Furthermore, fasting NEFA in
LC-DM patients showed significantly higher than
that in Control.
DISCUSSION
In this study, we did not find that there were cer-
tainly correlation between degree of glucose intol-
erance and severity of liver dysfunction in the pa-
tients with LC. It has been reported that incidence
of glucose intolerance in the patients with LC was
60-80% and defined DM was 10-60% (1, 2, 20).
To verify how many prevalence of glucose intol-
erance was observed in the patients with LC, 75 g
OGTT was firstly conducted in this study. The data
in OGTT were compared with those in Control. In
this study, the prevalence of NGT, IGT and DM was
34%, 20% and 46%, respectively. Hepatic glucose up-
take and peripheral glucose uptake were measured
simultaneously using HECGL. The validity of this
method for evaluating HGU had been ascertained
Table 2. Effects on meal ingestion on %REE, npRQ,npRQ and the concentration of plasma glucose (PG) and serum NEFA in
control and patients with liver cirrhosis
Control
Patients
LC-total LC-NGT LC-IGT LC-DM
%REE 8 : 30AM 93.31.8 94.61.5 95.83.1 99.12.7 92.62.1
(%) 11 : 30AM 102.82.8 105.61.8 107.93.9 111.64.4 102.12.0
2 : 30PM 109.23.0 113.72.4 113.94.0 123.18.2 110.02.4
npRQ 8 : 30AM 0.8010.016 0.7530.009 1 0.7850.017 0.7630.028 0.7320.010 1
11 : 30AM 0.8470.016 0.8700.011 0.8960.022 0.8770.036 0.8530.011
2 : 30PM 0.8660.019 0.8890.120 0.9130.014 0.8940.042 0.8730.162
npRQ 11 : 30AM-8 : 30AM 0.0480.015 0.1180.013 1 0.1110.021 0.1140.046 0.1240.018 1
2 : 30PM-8 : 30AM 0.0670.014 0.1360.155 1 0.1280.025 0.1310.053 0.1420.020 1
PG(mg/dl) 8 : 30AM 88.71.8 107.04.1 1 94.02.0 92.34.5 120.06.7 1,2,3
11 : 30AM 113.65.3 153.78.9 1 119.010.6 125.38.8 187.613.0 1,2,3
2 : 30PM 110.74.0 142.49.3 1 115.25.6 136.119.1 163.016.1 1,2
NEFA(μEq/L) 8 : 30AM 434.727.7 570.629.9 1 503.553.7 548.467.0 619.541.4 1
11 : 30AM 138.118.0 124.912.8 122.821.3 83.06.2 1 138.820.2
2 : 30PM 111.37.9 107.59.4 103.514.3 62.66.4 1 125.314.4 3
All values are meanSE. %REE : % of resting energy expenditure to basal energy expenditure, npRQ : nonprotein respiratory quotient,
npRQ : changes of npRQ, BG : blood glucose, NEFA : non esterified fatty acid
NGT : normal glucose tolerance, IGT : impaired glucose tolerance, DM : diabetes mellitus
1p0.05 vs. Control, 2p0.05 vs. LC-NGT, 3p0.05 vs. LC-IGT
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by the hepatic vein catheterization procedure in hu-
mans (15) and in dogs (21). In the present study,
GIR in the patients with LC was significantly lower
than that in normal subjects. Furthermore, HGU in
them was about 70% of that in Control. GIR de-
creased depend on severity of glucose intolerance.
But HGU did not show significant differences among
LC groups. i.e., severity of glucose intolerance was
seen to correlate with GIR but not HGU.
Recent studies using the hyperinsulinemic eu-
glycemic glucose clamp technique have reported
that peripheral insulin sensitivity in the patients with
LC was about 30-60% of that in healthy volunteers
(9, 10). The study using a positron-emission to-
mography study has clarified that in the patients
with LC impaired insulin action in the peripheral
tissues is characterized by both marked decrease in
glucose transport and nonoxidative glucose metabo-
lism under euglycemic state, however, glucose phos-
phorylation and glucose oxidation have been kept
to be intact (22). In addition, decreased insulin-in-
duced glycogen synthase activity was demonstrated
in isolated muscle samples from the patients with
LC (23).
More than 65% of the patients with LC show pro-
tein-energy malnutrition because of their increased
fat oxidation and decreased glucose oxidation (24).
It was reported that fat oxidation rate measured in
starved state after an overnight fast was increased
because glycogen stores in the patients with LC
was depleted in this condition (24). The nutritional
condition is frequently reduced and about 70% of the
patients with LC show some signs of malnutrition
(25). It is well recognized that malnutrition contrib-
utes to insulin resistance in the patients with LC
(4, 26). Furthermore, lipotoxicity by NEFA cause in-
sulin resistance (27, 28). With respect to REE, there
was no significant difference in REE between Con-
trol and LC patients. As patients with LC have been
reported to have either increased (29), normal (30,
31), or decreased (32) resting metabolic rates, this
issue remains controversial. The variability observed
in the patients with LC, although there was no sig-
nificant difference in REE between Control and the
patients with LC. Whenever available, indirect calo-
rimetry should be used to measure REE in the pa-
tients with LC.
The mass and function of hepatocytes is reduced
in the cirrhotic liver. Collagen accumulation in the
Disse’s space may disturb glucose permission from
endothelial cell of portal vein to hepatocytes (33, 34).
It also reported that insulin resistance is associated
with more rapid fibrosis progression in chronic HCV
infection (35, 36). Therefore, it is supposed that
complication with DM indicates the advance in liver
damage. The relation between glucose intolerance
and the biochemical parameters in liver dysfunc-
tion, degree of cirrhosis and energy metabolism in
the patients with LC was not observed. The aver-
age of estimated HGU in the patients with LC and
normal subjects were 41.4% and 58.3% in HECGL
study, respectively. Previous paper showed HGU
was lower in LC patients than in chronic active hepa-
titis patients and healthy volunteers (37). HGU did
not decrease depend on severity of glucose intol-
erance among LC groups. Thinking about severity
of glucose tolerance in LC, but HGU showed sig-
nificantly lower in LC patients than that in Control.
Therefore, our data indicated that postprandial glu-
cose uptake of the liver has already decreased in
the patients with LC.
The characteristics of glucose intolerance in the
patients with LC are unusual. Although some LC pa-
tients exhibit fasting hypoglycemia, they also have
postprandial hyperglycemia and continuous hy-
perinsulinemia (37). Our results also showed that
postprandial hyperglycemia was observed in the
patients with LC despite fasting glucose levels were
normal. In general, insulin resistance is considered
to be composed of the following three metabolic de-
fects : 1) reduced glucose uptake by the peripheral
tissues ; 2) decreased splanchnic glucose uptake ;
3) overproduction of glucose by the liver. Several
studies showed that peripheral and splanchnic glu-
cose utilization is known to be impaired as a result
of reduced nonoxidative glucose metabolism in
the patients with LC (i.e. , glycogen synthesis) (22,
37). Therefore, the main factor that contributes to
postprandial hyperglycemia may be associated with
insulin resistance.
It seemed that postprandial hyperinsulinemia
may overcome peripheral insulin resistance in the
patients with LC (38) so that NGT in OGTT was
observed in 30% of patients with LC. Therefore,
postprandial hyperglycemia might be one of other
compensatory mechanism to disorders in glucose
metabolism in the patients with LC, so that the over-
all glucose disposal is normal in some patients with
LC. These findings suggest that glucose intolerance
may be initiating event for indicating liver dysfunc-
tion and/or altered hepatic circulation in the patients
with LC at early stage.
Peripheral insulin resistance characterized by de-
creased glucose transport and reduced glycogen
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synthesis in skeletal muscle, whereas the insulin-
induced increases in glucose phosphorylation, gly-
colysis and glucose oxidation the patients with LC
were reported (4, 22, 23, 39). Though, increased
insulin level cannot ameliorate disturbed glycogen
synthesis and disproportional increase in lactate pro-
duction in the patients with LC (39). However, glu-
cose transport, glucose phosphorylation, glycolysis,
glucose oxidation and glycogen synthesis are all
impaired in the patients with type 2 DM (40). Fur-
thermore, it has been reported that further elevation
of insulin level can normalize glycogen synthesis
and glycolysis but not glucose oxidation and anaero-
bic glycolysis in the patients with DM (40). Thus,
changes in metabolic characteristics in the cirrhotic
patients complicated with DM were obvious. In
contrast, impaired insulin extraction and impaired
counter regulation based on reduced glycogen store
in liver tissue and abnormal glucagon secretion
(41). These facts suggest that the cirrhotic patients
complicated with DM will be fallen into hypoglyce-
mia.
We concluded from the present study that insulin
resistance in both liver and peripheral tissues is
the early etiology of metabolic abnormality in the
patients with LC and precious nutritional care will
be needed at early stage of LC.
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